RESUMEN
Non-pretrained, randomized adult rats were tested in a panic-inducing model of passive avoidance. Intravenous treatment with alkalinizing agents (sodium lactate 0.5 M, 0.5 ml/100 g b.wt., or NaHCO3, 0.5 mEq/100 g b.wt.), but not with a hypocalcemic dose of EDTA (75 mg/kg) 3 min before testing, significantly increased panic behavior. These data may support the hypothesis that panic attacks are due to alkalosis and not to lactate-induced hypocalcemia.
Asunto(s)
Alcalosis/psicología , Conducta Animal/fisiología , Miedo/fisiología , Hipocalcemia/psicología , Pánico/fisiología , Animales , Bicarbonatos/farmacología , Femenino , Lactatos/farmacología , Ácido Láctico , Distribución Aleatoria , Ratas , Ratas Endogámicas , Sodio/farmacología , Bicarbonato de SodioAsunto(s)
Médula Ósea/patología , Granulocitos/citología , Fallo Renal Crónico/sangre , Neutrófilos/citología , Diálisis Renal , Adolescente , Adulto , Anciano , Femenino , Humanos , Fallo Renal Crónico/terapia , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Prednisona , Valores de ReferenciaRESUMEN
Some hemorheological factors were studied in 34 patients affected by retinal vein occlusion (RVO) and in 25 healthy control subjects. Whole blood viscosity, plasma viscosity, fibrinogen and hematocrit were increased in RVO patients compared with controls. Erythrocyte filterability was reduced in RVO patients compared with controls. However, when evaluating the type of capillaropathy at fluorescein angiography, blood viscosity and plasma viscosity were altered both in patients with and without evidence of capillary non-perfusion. Reduction of red cell filterability showed statistical significance only in patients with capillary non-perfusion. This finding suggests that reduced erythrocyte filterability might be a causal factor in the development of capillary non-perfusion in RVO patients.
Asunto(s)
Viscosidad Sanguínea , Deformación Eritrocítica , Vena Retiniana , Adulto , Anciano , Femenino , Fibrinógeno/sangre , Hematócrito , Humanos , Masculino , Persona de Mediana Edad , Enfermedades de la Retina/fisiopatología , ReologíaRESUMEN
The effects of N-2-(p-chlorophenoxy)-isobutyryl-N'-morpholinomethylurea (plafibride, ITA 104) were studied in a trial under double which an increase in thromboembolic risk is suspected, either associated with, or secondary to, the actual atherosclerotic disease.